Okabe, S., Tauchi, T., Tanaka, Y., Sakuta, J., & Ohyashiki, K. (2015). Efficacy of the polo-like kinase inhibitor rigosertib, alone or in combination with Abelson tyrosine kinase inhibitors, against break point cluster region-c-Abelson-positive leukemia cells. Oncotarget.

Okabe, Seiichi, Tetsuzo Tauchi, Yuko Tanaka, Juri Sakuta, and Kazuma Ohyashiki. "Efficacy of the Polo-like Kinase Inhibitor Rigosertib, Alone or in Combination With Abelson Tyrosine Kinase Inhibitors, against Break Point Cluster Region-c-Abelson-positive Leukemia Cells." Oncotarget 2015.

Okabe, Seiichi, et al. "Efficacy of the Polo-like Kinase Inhibitor Rigosertib, Alone or in Combination With Abelson Tyrosine Kinase Inhibitors, against Break Point Cluster Region-c-Abelson-positive Leukemia Cells." Oncotarget 2015.